Document Detail


Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.
MedLine Citation:
PMID:  19486709     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Primary care physicians frequently provide contraceptive counseling to women who are interested in family planning, have medical conditions that may be worsened by pregnancy, or have medical conditions that necessitate the use of potentially teratogenic medications. Effective counseling requires up-to-date knowledge about hormonal contraceptive methods that differ in hormone dosage, cycle length, and hormone-free intervals and are delivered by oral, transdermal, transvaginal, injectable, or implantable routes. Effective counseling also requires an understanding of a woman's preferences and medical history as well as the risks, benefits, side effects, and contraindications of each contraceptive method. This article is designed to update physicians on this information.
Authors:
Abby L Spencer; Rachel Bonnema; Megan C McNamara
Related Documents :
15191789 - Oral delivery of medications to companion animals: palatability considerations.
16208799 - Plaque removal efficacy of two electric toothbrushes with different brush head designs.
2197099 - Metamizole: reassessment of its therapeutic role.
15114429 - Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for cyp3...
17048499 - Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecul...
6643209 - Apparent oral contraceptive failure associated with antibiotic administration.
20500649 - Non-therapeutic omission of medications in acutely ill patients.
7899919 - Stigma: the hidden burden of infertility.
14968889 - Autonomic syncope in pediatrics: a practice-oriented approach to classification, pathop...
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  The American journal of medicine     Volume:  122     ISSN:  1555-7162     ISO Abbreviation:  Am. J. Med.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-02     Completed Date:  2009-06-19     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  497-506     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Section of General Internal Medicine, Allegheny General Hospital, Pittsburgh, PA 15212, USA. aspence1@wpahs.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Clinical Trials as Topic
Contraception / methods*
Contraceptive Agents, Female / administration & dosage*,  adverse effects
Contraceptives, Oral, Hormonal / administration & dosage
Counseling*
Desogestrel / administration & dosage
Evidence-Based Medicine
Family Planning Services
Family Practice
Female
Humans
Injections, Intramuscular
Injections, Subcutaneous
Levonorgestrel / administration & dosage
Medroxyprogesterone Acetate / administration & dosage
Ovulation Inhibition / drug effects
Practice Guidelines as Topic
Pregnancy
Risk Factors
Women's Health*
World Health Organization
Chemical
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Contraceptives, Oral, Hormonal; 54024-22-5/Desogestrel; 54048-10-1/3-keto-desogestrel; 71-58-9/Medroxyprogesterone Acetate; 797-63-7/Levonorgestrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Laser photoablation of guidance microchannels into hydrogels directs cell growth in three dimensions...
Next Document:  Current evaluation and treatment of lower extremity varicose veins.